LY3962681

LY3962681 · Prevail Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3962681, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease [Phase 1]